Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion.
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2012
At a glance
- Drugs NN 7128 (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- 04 Sep 2012 Not official study title and study phase estimated
- 04 Sep 2012 New trial record
- 01 Aug 2012 Results published in Transfusion.